Scopus BioPharma (SCPS) Short Interest Ratio & Short Volume → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free SCPS Stock Alerts $0.0021 +0.00 (+90.91%) (As of 10:03 AM ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial Media Scopus BioPharma Short Interest DataCurrent Short Volume60,400 sharesPrevious Short Volume23,800 sharesChange Vs. Previous Month+153.78%Dollar Volume Sold Short$20,542.04Short Interest Ratio / Days to Cover0.1Last Record DateDecember 15, 2022Outstanding Shares42,080,000 sharesFloat Size7,170,000 sharesShort Percent of Float0.84%Today's Trading Volume172 sharesAverage Trading Volume5,933 sharesToday's Volume Vs. Average3% Short Selling Scopus BioPharma ? Sign up to receive the latest short interest report for Scopus BioPharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSCPS Short Interest Over TimeSCPS Days to Cover Over TimeSCPS Percentage of Float Shorted Over Time Ad Unstoppable Prosperity“Crash Insurance” For Your RetirementWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. Scopus BioPharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/202260,400 shares $20,542.04 +153.8%0.8%0.1 $0.34 11/30/202223,800 shares $5,240.76 -38.0%0.3%0.1 $0.22 11/15/202238,400 shares $9,411.84 +96.9%0.5%0.1 $0.25 10/31/202219,500 shares $4,910.10 -21.1%0.3%0.1 $0.25 10/15/202224,700 shares $6,034.21 -39.8%0.3%0.1 $0.24 9/30/202241,000 shares $9,926.10 +215.4%0.6%0.5 $0.24 Get the Latest News and Ratings for SCPS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Scopus BioPharma and its competitors with MarketBeat's FREE daily newsletter. 9/15/202213,000 shares $4,075.50 +282.4%0.2%0.1 $0.31 8/31/20223,400 shares $1,180.48 -88.3%0.1%0 $0.35 8/15/202229,100 shares $12,804.00 +62.6%0.4%0.4 $0.44 7/31/202217,900 shares $6,794.84 -3.8%0.3%0.3 $0.38 7/15/202218,600 shares $6,986.16 -65.6%0.3%0.3 $0.38 6/30/202254,100 shares $23,263.00 -70.1%0.8%0.8 $0.43 6/15/2022180,800 shares $72,555.04 +80.8%2.5%2.1 $0.40 5/31/2022100,000 shares $39,430.00 +82.5%1.4%0.4 $0.39 5/15/202254,800 shares $22,468.00 -39.4%0.8%0.2 $0.41 4/30/202290,400 shares $43,663.20 +7.9%1.3%0.3 $0.48 4/15/202283,800 shares $54,335.84 +11.4%1.2%0.3 $0.65 3/31/202275,200 shares $51,970.72 -23.7%1.1%0.2 $0.69 3/15/202298,600 shares $61,171.44 +282.2%1.4%0.3 $0.62 2/28/202225,800 shares $18,705.00 -65.4%0.4%0.2 $0.73 2/15/202274,600 shares $63,037.00 +20.3%1.0%0.7 $0.85 1/31/202262,000 shares $70,060.00 -15.3%1.3%0.8 $1.13 1/15/202273,200 shares $101,748.00 +11.6%1.8%0.9 $1.39 12/31/202165,600 shares $107,256.00 +1.7%1.6%0.8 $1.64 12/15/202164,500 shares $127,710.00 +5.2%1.6%0.7 $1.98 11/30/202161,300 shares $152,024.00 -21.6%1.5%0.6 $2.48 11/15/202178,200 shares $275,264.00 -9.6%1.8%0.3 $3.52 10/29/202186,500 shares $292,370.00 -21.2%2.0%0.3 $3.38 10/15/2021109,700 shares $437,703.00 -7.9%2.5%0.2 $3.99 9/30/2021119,100 shares $494,265.00 +88.2%2.7%0.3 $4.15 9/15/202163,300 shares $363,975.00 -16.7%1.5%0.1 $5.75 8/31/202176,000 shares $417,240.00 -19.7%5.6%0.2 $5.49 8/13/202194,600 shares $428,538.00 +266.7%3.3%0.1 $4.53 7/30/202125,800 shares $119,970.00 -52.4%0.6%0 $4.65 7/15/202154,200 shares $307,856.00 -6.9%1.2%0.1 $5.68 6/30/202158,200 shares $415,548.00 -56.8%1.0%0.1 $7.14 6/15/2021134,700 shares $961,758.00 -34.7%2.4%0.2 $7.14 5/28/2021206,400 shares $1.46 million +47.9%3.7%0.2 $7.08 5/14/2021139,600 shares $721,732.00 +26.2%2.5%0.2 $5.17 4/30/2021110,600 shares $843,878.00 +26.4%1.7%1 $7.63“Crash Insurance” For Your Retirement (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. SCPS Short Interest - Frequently Asked Questions What is Scopus BioPharma's current short interest? Short interest is the volume of Scopus BioPharma shares that have been sold short but have not yet been closed out or covered. As of December 15th, investors have sold 60,400 shares of SCPS short. 0.84% of Scopus BioPharma's shares are currently sold short. Learn More on Scopus BioPharma's current short interest. What is a good short interest percentage for Scopus BioPharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.84% of Scopus BioPharma's floating shares are currently sold short. Is Scopus BioPharma's short interest increasing or decreasing? Scopus BioPharma saw a increase in short interest during the month of December. As of December 15th, there was short interest totaling 60,400 shares, an increase of 153.8% from the previous total of 23,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Scopus BioPharma's float size? Scopus BioPharma currently has issued a total of 42,080,000 shares. Some of Scopus BioPharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Scopus BioPharma currently has a public float of 7,170,000 shares. How does Scopus BioPharma's short interest compare to its competitors? 0.84% of Scopus BioPharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Scopus BioPharma: Bruush Oral Care Inc. (76.99%), Context Therapeutics Inc. (0.29%), Grifols, S.A. (2.57%), LAVA Therapeutics (1.37%), Mainz Biomed (2.30%), NLS Pharmaceutics Ltd. (0.34%), Pharvaris (0.87%), Aditxt, Inc. (10.83%), Aptevo Therapeutics Inc. (9.10%), China SXT Pharmaceuticals, Inc. (11.61%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.47 billion), Suncor Energy Inc. ($2.33 billion), T. Rowe Price Group, Inc. ($2.14 billion), PG&E Co. ($1.61 billion), Etsy, Inc. ($1.56 billion), Paramount Global ($1.53 billion), Old Dominion Freight Line, Inc. ($1.49 billion), Coinbase Global, Inc. ($1.46 billion), DICK'S Sporting Goods, Inc. ($1.30 billion), and C.H. Robinson Worldwide, Inc. ($1.26 billion). View all of the most shorted stocks. What does it mean to sell short Scopus BioPharma stock? Short selling SCPS is an investing strategy that aims to generate trading profit from Scopus BioPharma as its price is falling. SCPS shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Scopus BioPharma? A short squeeze for Scopus BioPharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SCPS, which in turn drives the price of the stock up even further. How often is Scopus BioPharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SCPS, twice per month. The most recent reporting period available is December, 15 2022. More Short Interest Resources from MarketBeat Related Companies: Bruush Oral Care Short Squeeze Context Therapeutics Short Squeeze Grifols Short Squeeze LAVA Therapeutics Short Squeeze Mainz Biomed Short Squeeze NLS Pharmaceutics Short Squeeze Pharvaris Short Squeeze Tiziana Life Sciences Short Squeeze Aditxt Short Squeeze Aptevo Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SCPS) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyAI “wealth window” is closing June 25thParadigm PressGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarnings